Comparison 13. Adequate concealment spasmolytic agents: global assessment.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 comparing nrs of successfully treated IBS patients with spasmolytic agents | 3 | 219 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.35 [0.85, 2.12] |